Development of a primary cutaneous CD30(+) anaplastic large-cell T-cell lymphoma during treatment of multiple sclerosis with fingolimod

Conclusion: Causality of fingolimod is indicated by the fact that the skin lesions appeared after commencement of treatment and resolved after discontinuation of therapy. This case serves as a reminder of the potential side effects of fingolimod.

http://msj.sagepub.com/cgi/content/abstract/22/14/1888?rss=1

Source: Multiple Sclerosis - December 8, 2016 Category: Neurology Authors: Papathemeli, D., Gräfe, R., Hildebrandt, U., Zettl, U. K., Ulrich, J. Tags: Case Report Source Type: research